Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Medcaw Investments PLC ( (GB:MCI) ) just unveiled an announcement.
Medcaw Investments PLC announced its audited financial results for the year ending December 31, 2024, revealing a loss of £432,360, an improvement from the previous year’s loss of £712,170. The company decided not to proceed with the proposed reverse transaction with Abyssinian Metals Limited due to an ongoing dispute involving the Kenticha Lithium project in Ethiopia. Medcaw’s shares resumed trading on the London Stock Exchange, and the company is actively searching for new acquisition targets.
More about Medcaw Investments PLC
Medcaw Investments PLC operates in the investment industry, primarily focusing on pursuing acquisitions. The company is listed on the London Stock Exchange and aims to identify and acquire promising business opportunities.
Average Trading Volume: 255,000
Technical Sentiment Signal: Buy
Learn more about MCI stock on TipRanks’ Stock Analysis page.